Skip to content

Clinical trials

Phase 2 Cognitive Dysfunction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 2 Country / region: United States Clear all

193 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20053
20068
20072
20087
20098
20103
201111
20126
20134
20146
20155
20165
201714
201811
201910
20207
202124
20229
20237
202414
202513
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed112
Recruiting29
Active, not recruiting16
Terminated16
Unknown status6
Withdrawn5
Not yet recruiting5
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University6
Wake Forest University Health Sciences6
Mayo Clinic5
Columbia University4
Eli Lilly and Company4
Supernus Pharmaceuticals, Inc.4
University of Washington4
Vanderbilt University Medical Center4
Weill Medical College of Cornell University4
Avid Radiopharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction193
Alzheimer Disease90
Dementia28
Memory Disorders13
Cognition Disorders11
Schizophrenia11
Delirium8
Inflammation7
Brain Diseases6
Parkinson Disease6

Trials

Showing 1 to 25 of 193. Each trial links to its page on Pharma Observatory.

93 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.